Are post-op but have not yet reached their weight loss goal
Due to enzymatic degradation and renal clearance (29), endogenous GLP-1 has a short half-life of 1-2 min (30,31)
Venus M, Waterman J, McNab I (2010) Basic physiology of the skin
Limitations of a Symptom-Suppression Pain Model While medications and injections may reduce pain temporarily, they often: Do not correct structural imbalance or tissue degeneration Fail to resolve inflammatory or immune-driven pain Overlook metabolic contributors such as blood sugar instability or nutrient depletion Ignore nervous system sensitization and central pain amplification that perpetuate chronic pain As a result, pain frequently returnssometimes requiring higher doses, repeated injections, or additional medications to maintain relief
Fosamax (alendronate sodium) Prescribing Information
While the role of the medication in promoting weight loss is well established, its potential to reduce the frequency of HS flares could revolutionize the treatment approach for patients struggling with this condition. In light of these encouraging data, Dr